Biotech ETF Rises 17% in a Month Without NVIDIA
A biotech ETF posts a 17% gain in the trailing month even as NVIDIA weakens, underscoring a sector rotation that chal...
Discover reliable places to access index level fundamentals and tips for evaluating the credibility and timeliness of the data you use.
17,495 articlesA biotech ETF posts a 17% gain in the trailing month even as NVIDIA weakens, underscoring a sector rotation that chal...
As 2026 unfolds with economic and geopolitical headwinds, investors look to five Dividend Aristocrats for steady inco...
Moderna stock has surged on vaccine optimism and pipeline potential. This guide breaks down what’s behind the move, w...
Three sector ETFs are beating the Nasdaq tech index in 2026, signaling a shift toward defense tech, electrification, ...
The AI hype loop is loud, but investors want results. This piece breaks down what mark zuckerberg admitted agents cou...
A 28-year-old with $730,000 zero debt asks Dave Ramsey for guidance on next steps, sparking a broader look at how you...
A new set of futures is coming to the CME Group, tying Tesla and SpaceX to a cash-settled futures contract. This arti...
Analysts project a multi-year path for novo nordisk (nvo) stock, supported by strong product momentum but tempered by...
Retirees often seek steady income with minimal fuss. These magnificent ETFs retirees that pay above 3% can fit a simp...
When yields rise, even patient investors can feel the pressure. This guide explains what rising treasury yields spook...
AI memory demand sent memory-chipmakers like Micron and SK Hynix soaring. But the investing legend John Templeton wou...
Retirees face rising costs and market surprises. This guide explains why building several income streams matters in 2...